Actavis Expands Manufacturing Operations in Puerto Rico - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Actavis Expands Manufacturing Operations in Puerto Rico



The Puerto Rico Industrial Development Company (PRIDCo) and Actavis announced that the company will develop a solid dosage manufacturing and packing facility at its Manati site and expand its current hormone production in Fajardo.

Actavis is investing $48 million and has committed to create up to 300 new jobs over a 36-month period; it has already has created 100 jobs. The investment will allow the company to bring new lines of generic, brand, and biosimilar products. When the expansion is completed, Actavis will have 700 employees in Puerto Rico.

All plans are expected to be complete by 2016.

Source: Puerto Rico Industrial Development Company

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here